1. Market Research
  2. > Pharmaceutical Market Trends
Indian Peptides and Heparin Market by Type, Application - Forecast to 2022

Indian Peptides and Heparin Market: Forecast until 2022

  • August 2017
  • 77 pages
  • ID: 5077133
In this report:
The enoxaparin sodium segment is expected to reach USD ##.## million by 2022 from USD ##.## million by 2016, at a CAGR of ##.##%.
This segment is expected to reach USD ##.## million by 2022 from USD ##.## million in 2016, at a CAGR of ##.##% during the forecast period.
The calcitonin-salmon segment is expected to reach USD ##.## million by 2022 from USD ##.## million in 2016, at a CAGR of ##.##%.

Summary

Table of Contents

Search Inside

"Indian Peptides and Heparin Market forecasted to grow at a compound annual growth rate (CAGR) of 15.00 percent and 4.90 percent respectively"

The Indian peptides market is forecasted to reach $883.00M in 2022 from $381.80M in 2016 and is anticipated to register a CAGR (Compound annual growth rate) of 15.00 percent, and the Indian heparin market is estimated to grow $170.20M by 2022, at a compound annual growth rate of 4.90 percent. Elements such as growing prevalence of chronic diseases, rising incidence of coagulation disorder, and favorable government policies are the main driving factors for the Indian peptides and heparin market. On the other hand, the availability of alternative drugs is the main restraining factor for the Indian peptides market. The patent expiry of blockbuster drugs will provide increase opportunities to actors in the Indian peptides market. For example, Victorza is the brand name of the liraglutide peptide developed by Novo Nordisk. Its patent will expire in August 2017, which will enable drug manufacturers to introduce their generic versions of it.

"Bivalirudin type is forecasted to register the more significant increase during the outlook period"

The Indian peptides market is classified on the basis of category into insulin, teriparatide, liraglutide, glucagon, leuprolide acetate, octreotide acetate, calcitonin salmon, triptorelin, eptifibatide, glatiramer acetate, bivalirudin, exenatide, and other molecules. The bivalirudin segment is forecasted to record the highest compound annual growth rate (CAGR) during the estimate period. This rise can be connected to the growing number of percutaneous coronary intervention procedures in India (IN).

"Appreciation about early diagnosis drives increase of the diabetes segment"

By application, the Indian peptides market is broken down into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological applications, and other applications. The diabetes segment is projected to record topmost cagr during the outlook period. The rise in this industry segment can be primarily attributed to rising awareness of early diagnosis, growing prevalence & incidence of diabetes, and growing aging population.

Top competitors operating in the Indian peptides market contain Abbott Laboratories (NYSE:ABT), Sanofi S.A., Eli Lilly and Organization, Cipla Limited, Biocon Limited, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Cadila Pharmaceuticals, Lupin Limited, Emcure Pharmaceuticals Ltd., Novartis International AG, Dr. Reddy's Laboratories Limited, and Alkem Laboratories Limited.

"Enoxaparin sodium type is expected to record the more significant increase during the estimate period"

The Indian heparin market is classified on the basis of class into enoxaparin sodium, heparin sodium, fondaparinux, and dalteparin sodium. The enoxaparin sodium type segment is projected to register the more important rise during the outlook period. This increase can be accredited to the growing coagulation disorders in the area.

Key competitors operating in the Indian heparin market contain Sanofi, Emcure Pharmaceutical Pvt. Limited, Cipla Ltd., Bharat Serum, Pfizer Inc., Abbott Laboratories, Lupin Ltd., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Samarth Life Sciences, Claris Lifesciences Limited, Gland Pharma Limited, Mylan Pharmaceutical, Torrent Pharmaceuticals, Micro Labs Ltd., and VHB Lifesciences.

The primary interviews conducted for this business report can be categorized as follows:

• By Company category - Tier 1 - 70 %, Tier 2 - 30.0 percent

• By Description - C-suite - 62.0 percent, D-level - 21.0 percent, Others - 17.0 percent

Segment Research

The report analyses the Indian peptides market by category and application and the Indian heparin market by category. Apart from comprehensive product review and sizing of market, the study also offers the complete list of peptide and heparin manufacturers and marketing actors in India (IN). Additionally, the report profiles firms with product types and main financial data by top players to maintain and rise their companies in the sector. The abovementioned market research data, market value, and projection of future trends will facilitate top market players and new sector entrants to make the necessary decisions to be successful in the market.

Benefits of Buying this Report:

This industry report will allow both established firms as well as new entrants/smaller companies gauge the pulse of the sector, which in turn will facilitate these companies collect greater segment market share. Companies obtaining the analysis can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The market research offers business insights on the following strategies:

• Market Uptake: Exhaustive data on the product portfolios of the top actors in the Indian peptides and heparin market. The report analyses the Indian peptides market by category and application and the Indian heparin market by category.

• Competitive Assessment: In-depth assessment of the market strategies, industry segments, and product review of the main players in the Indian peptides and heparin market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Polymeric Adsorbents Market by Type, Modified Aromatic, Methacrylic), End-Use Industry And Region - Global Forecast to 2022

Polymeric Adsorbents Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • September 2017
  • by MarketsandMarkets

“The polymeric adsorbents market is projected to grow at a CAGR of 7.9% from 2017 to 2022”The polymeric adsorbents market was valued at USD 86 million in 2016 and is projected to reach USD 135.20 million ...

Vaccine Market by Technology, Disease, Route, End User & Type - Forecast to 2022

Vaccine Market: Forecast until 2022

  • $ 5650
  • Industry report
  • August 2017
  • by MarketsandMarkets

“Global vaccines market projected to grow at a CAGR of 7.5%”The vaccines market is expected to reach USD 49.27 billion by 2022 from USD 34.30 billion in 2017, at a CAGR of 7.5%. Rising prevalence of ...

Drug Discovery Services Market by Process, Type, Drug Type, Therapeutic Areas - Forecast to 2022

Drug Discovery Services Market: Forecast until 2022

  • $ 5650
  • Industry report
  • October 2017
  • by MarketsandMarkets

“The drug discovery services market projected to grow at a CAGR of 11.6%.”The drug discovery services market was valued at USD 8.32 billion in 2017 and expected to grow at a CAGR of 11.6% to reach ...

France: Pharmaceuticals market $ 657 November 2017


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.